Effectiveness of Dupilumab Treatment in Patients With Type 2 Inflammation: A Real-Life Integrated Experience
Understanding the interconnection between different type 2 inflammatory diseases provides insight into potential avenues for precision medicine approaches and targeted therapies.
Authors
- Mirta Cavallini
- Alice D’Adda
- Sara Torretta (ORCID: https://orcid.org/0000-0002-8461-6042)
- Chiara Bellocchi (ORCID: https://orcid.org/0000-0001-8326-7904)
- Ludovica Battilocchi (ORCID: https://orcid.org/0000-0003-0897-3264)
- Lorenzo Pignataro (ORCID: https://orcid.org/0000-0003-1619-5124)
- Federica Rivolta (ORCID: https://orcid.org/0000-0002-4693-5632)
- G. Piatti
- Simona Tavecchio (ORCID: https://orcid.org/0000-0003-3546-4932)
- C Catalano (ORCID: https://orcid.org/0000-0002-9999-6404)
- Silvia Ferrucci
Institutions
- University of Milan (IT)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
Publication Details
- Journal
- Therapeutic Advances in Allergy and Rhinology
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1177/27534030241312540
- Citations
- 1
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.16